New hope to slow advanced throat cancer
NCT ID NCT03581786
Summary
This study tested if adding a new immunotherapy drug called toripalimab to standard chemotherapy could better control advanced or returning nasopharyngeal cancer. About 289 patients with this type of throat cancer were randomly assigned to receive either the new drug combination or chemotherapy with a placebo. The main goal was to see if the new combination could slow the cancer's progression and extend patients' lives compared to chemotherapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC NPC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Guangzhou, Guangdong, 510095, China
-
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangzhou, 130012, China
-
Cancer Hospital of Shantou University Medical College
Shantou, Guangzhou, 515031, China
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital
Taoyuan District, 333, Taiwan
-
China Medical University Hospital
Taichung, 404, Taiwan
-
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, 200032, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350000, China
-
Fujian Provincial Cancer Hospital
Fuzhou, Fujian, 350000, China
-
Hainan General Hospital (Hainan Province People's Hospital)
Haikou, Hainan, 570311, China
-
Hebei Oncology Hospital
Shijiazhuang, Hebei, 50011, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Jiangsu Oncology Hospital
Nanjing, Jiangsu, 210000, China
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 330029, China
-
Liuzhou Worker's Hospital
Liuchow, Guangxi, 545000, China
-
Nanfang Hospital
Guangzhou, Guangdong, 510515, China
-
National Cancer Centre
Singapore, 169610, Singapore
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
Shanghai General Hospital
Shanghai, Shanghai Municipality, 200080, China
-
Shenzhen People's Hospital
Shenzhen, Guangdong, 518020, China
-
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
TaiChung Veterans General Hospital
Taichung, 40705, Taiwan
-
Taipei Veterans General Hospital
Taipei, 112, Taiwan
-
Tan Tock Seng Hospital
Singapore, 308433, Singapore
-
The Affiliated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou, 550000, China
-
The Fifth Affiliated Hospital Sun Yat-Sen University - Medical Oncology
Zhuhai, Guangzhou, 519000, China
-
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, 530021, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & TechnologyTongji Hospital
Wuhan, Hubei, 430030, China
-
Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, 430023, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.